In the interest of service and due to the continuing COVID-19 Pandemic, the effectivity of FDA Circular No. 2020-022 entitled “Reissuance of the Guidelines on the Identification, Notification, Evaluation, Regulatory Enforcement Action, and Review and Monitoring of Donated Health Products Solely Intended to Address COVID-19 Public Health Emergency” is hereby extended until 12 September 2021.
For the information and guidance of the public.
Attachment:-> FDA Circular No.2020-022-A